Changing the Name of Diabetes Insipidus: A Position Statement of the Working Group for Renaming Diabetes Insipidus.

arginine vasopressin deficiency arginine vasopressin resistance diabetes insipidus nephrogenic pituitary

Journal

The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362

Informations de publication

Date de publication:
17 12 2022
Historique:
received: 09 09 2022
pubmed: 11 11 2022
medline: 21 12 2022
entrez: 10 11 2022
Statut: ppublish

Résumé

Recent data show that patients with a diagnosis of diabetes insipidus (DI) are coming to harm. Here we give the rationale for a name change to arginine vasopressin deficiency and resistance for central and nephrogenic DI, respectively.

Identifiants

pubmed: 36355385
pii: 6820279
doi: 10.1210/clinem/dgac547
pmc: PMC9759163
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-3

Investigateurs

Hiroshi Arima (H)
Timothy Cheetham (T)
Mirjam Christ-Crain (M)
Mark Gurnell (M)
Deborah Cooper (D)
Juliana Drummond (J)
Miles Levy (M)
Mark Gurnell (M)
Ann McCormack (A)
Joseph G Verbalis (JG)
John Newell-Price (J)
John Wass (J)

Informations de copyright

© The Author(s). Published by Oxford University Press on behalf of the Endocrine Society.

Références

Pituitary. 2004;7(1):33-8
pubmed: 15638296
Presse Med. 2008 Feb;37(2 Pt 1):250-1
pubmed: 18164176
J Lab Clin Med. 1983 Mar;101(3):351-71
pubmed: 6338137
Clin Endocrinol (Oxf). 2018 May;88(5):625-626
pubmed: 29460326
Bull N Y Acad Med. 1972 Sep;48(8):1033-6
pubmed: 4560481
J Am Acad Dermatol. 2005 Oct;53(4):720-3
pubmed: 16198806
Arthritis Care Res. 2000 Aug;13(4):237-45
pubmed: 14635278
Acta Eur Fertil. 1975 Dec;6(4):331-8
pubmed: 1243606
Lancet Diabetes Endocrinol. 2022 Oct;10(10):700-709
pubmed: 36007536
Lancet. 2006 Apr 22;367(9519):1362-6
pubmed: 16631915

Auteurs

Hiroshi Arima (H)

Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.

Timothy Cheetham (T)

Department of Pediatric Endocrinology, Newcastle University, Newcastle upon Tyne NE1 7RU, UK.
Great North Children's Hospital (GNCH), Newcastle upon Tyne NE1 4LP, UK.

Mirjam Christ-Crain (M)

Department of Endocrinology, University Hospital and University of Basel, CH-4031 Basel, Switzerland.

Deborah Cooper (D)

The Pituitary Foundation, Bristol BS1 5BB, UK.

Juliana Drummond (J)

Department of Internal Medicine, School of Medicine, Federal University of Minas Gerais, Belo Horizonte, MG CEP 31270-901, Brazil.

Mark Gurnell (M)

Wellcome-MRC Institute of Metabolic Science, University of Cambridge & Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.

Miles Levy (M)

Department of Endocrinology, University Hospitals of Leicester NHS Trust, Leicester LE3 9QP, UK.

Ann McCormack (A)

Department of Endocrinology, St Vincent's Hospital, Sydney, NSW 2010, Australia.
Garvan Institute of Medical Research, Sydney, NSW 2010, Australia.
St Vincent's Clinical School, University of New South Wales, Sydney, NSW 2052, Australia.

John Newell-Price (J)

Department of Oncology and Metabolism, The Medical School, University of Sheffield, Sheffield S10 2RX, UK.

Joseph G Verbalis (JG)

Division of Endocrinology and Metabolism, Georgetown University Medical Center, Washington, DC 20007, USA.

John Wass (J)

Department of Endocrinology, University of Oxford, Churchill Hospital, Oxford OX3 7LE, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH